​

INmune Bio (INMB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INMB Stock Forecast

INmune Bio (INMB) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $22.00, with a high of $22.00 and a low of $22.00. This represents a 1095.65% increase from the last price of $1.84.

- $5 $10 $15 $20 $25 High: $22 Avg: $22 Low: $22 Last Closed Price: $1.84

INMB Stock Rating

INmune Bio stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 2 Hold (25.00%), 1 Sell (12.50%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 2 5 Strong Sell Sell Hold Buy Strong Buy

INMB Price Target Upside V Benchmarks

TypeNameUpside
StockINmune Bio1095.65%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.84$1.84$1.84
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25123--6
Sep, 25123--6
Aug, 25132-17
Jul, 25122-16
Jun, 2532---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 22, 2024George FarmerScotiabank$22.00$6.85221.17%1095.65%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 26, 2024Raymond JamesOutperforminitialise
Sep 18, 2024ScotiabankSector OutperformSector Outperformhold
Sep 18, 2024BTIGBuyBuyhold
Aug 21, 2024ScotiabankOutperforminitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.88$-1.60$-1.67-----
Avg Forecast$-1.91$-1.66$-1.65$-2.30$-2.01$-1.86$-0.72$0.13
High Forecast$-1.91$-1.66$-1.53$-2.30$-2.01$-1.60$2.66$0.13
Low Forecast$-1.91$-1.66$-1.78$-2.30$-2.01$-2.06$-1.90$0.13
Surprise %-1.57%-3.61%1.21%-----

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$181.00K$374.00K$155.00K$14.00K----
Avg Forecast$10.67K$195.50K$141.33K$10.00K$25.00K$25.00K$55.12M$97.10M
High Forecast$10.67K$195.50K$184.82K$10.34K$25.00K$25.00K$55.12M$97.10M
Low Forecast$10.67K$195.50K$108.72K$9.66K$25.00K$25.00K$55.12M$97.10M
Surprise %1596.82%91.30%9.67%40.00%----

Net Income Forecast

$-45M $-26M $-7M $12M $31M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.34M$-28.65M$-30.01M$42.08M----
Avg Forecast$-34.41M$-29.85M$-30.01M$-41.31M$-36.21M$-32.90M$-20.93M$2.29M
High Forecast$-34.41M$-29.85M$-27.54M$-41.31M$-36.21M$-28.77M$47.89M$2.29M
Low Forecast$-34.41M$-29.85M$-31.98M$-41.31M$-36.21M$-37.04M$-34.21M$2.29M
Surprise %-11.84%-4.02%--201.87%----

INMB Forecast FAQ

Is INmune Bio stock a buy?

INmune Bio stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that INmune Bio is a favorable investment for most analysts.

What is INmune Bio's price target?

INmune Bio's price target, set by 8 Wall Street analysts, averages $22 over the next 12 months. The price target range spans from $22 at the low end to $22 at the high end, suggesting a potential 1095.65% change from the previous closing price of $1.84.

How does INmune Bio stock forecast compare to its benchmarks?

INmune Bio's stock forecast shows a 1095.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for INmune Bio over the past three months?

  • October 2025: 16.67% Strong Buy, 33.33% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 16.67% Strong Buy, 33.33% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 14.29% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 14.29% Strong Sell.

What is INmune Bio’s EPS forecast?

INmune Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.01, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-1.86 in 2026, $-0.72 in 2027, and $0.13 in 2028.

What is INmune Bio’s revenue forecast?

INmune Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $25K, reflecting a 78.57% increase from the reported $14K in 2024. The forecast for 2026 is $25K, followed by $55.12M for 2027, and $97.1M for 2028.

What is INmune Bio’s net income forecast?

INmune Bio's net income forecast for the fiscal year ending in December 2025 stands at $-36.206M, representing a -186.04% decrease from the reported $42.08M in 2024. Projections indicate $-32.901M in 2026, $-20.934M in 2027, and $2.29M in 2028.